Vanderbilt Heart and Vascular Institute Archives

VUMC lauded for hypertrophic cardiomyopathy care

Oct. 21, 2021—Vanderbilt University Medical Center was recently named a center of excellence for hypertrophic cardiomyopathy by the Hypertrophic Cardiomyopathy Association.

VHVI reaches milestone in cardiac monitor implants

Sep. 15, 2021—Vanderbilt has reached a new milestone in implanting CardioMEMS remote cardiac monitoring devices.

VHVI offers latest therapies to treat atrial fibrillation

Sep. 9, 2021—Vanderbilt Heart and Vascular Institute continues to offer the latest in therapies to treat atrial fibrillation (AF or AFib), the most common cardiac arrhythmia.

After receiving his LVAD, patient Brandon Cochran was able to leave the hospital and spend more time with his wife, Amy, and daughters Olivia and Stella.

Novel LVAD allows patient to see family, celebrate milestones

Sep. 2, 2021—Brandon Cochran, a 39-year-old real estate agent in Louisville, Kentucky, was at home with his family in October 2020 when he went into cardiac arrest. His implanted defibrillator shocked him back to life, and he was hospitalized for seven months.

The Structural Heart and Valve Center team has recently completed multiple groundbreaking transcatheter clinical trial procedures treating severe regurgitation of the mitral and tricuspid valves.

Structural Heart and Valve Center reaches procedure milestones

Aug. 12, 2021—The Structural Heart and Valve Center at Vanderbilt Heart and Vascular Institute (VHVI) has recently completed multiple groundbreaking transcatheter clinical trial procedures treating severe regurgitation of the mitral and tricuspid valves, a continuation of a decade of research that is revolutionizing the treatment of these conditions.

Anticoagulation Clinic at Vanderbilt Heart designated an Anticoagulation Center of Excellence

Jun. 9, 2021—The Anticoagulation Clinic at Vanderbilt Heart and Vascular Institute (VHVI) has been designated an Anticoagulation Center of Excellence by the Anticoagulation Forum, one of only three in Tennessee.

New Clinician Spotlight: Matthews Chacko

Apr. 8, 2021—Matthews Chacko, MD, has joined Vanderbilt Heart and Vascular Institute as an assistant professor of Medicine, an interventional cardiologist and the director of peripheral vascular interventions.

The diversity represented at Vanderbilt Heart Murfreesboro includes, from left, Ahmad Abu-Halimah, MD, Murali Kolli, MD, Ravinder Manda, MD, and David Dantzler, MD.

Murfreesboro heart clinic reveals power of diversity

Mar. 10, 2021—In suburban Murfreesboro, just a short drive off Interstate 24, is one of the most diverse practices and clinics in Vanderbilt Health.

Congenital Heart Program gains accreditation from ACHA

Jan. 21, 2021—The Adult Congenital Heart Association (ACHA) has awarded the Vanderbilt Adult Congenital Heart Program status as an Adult Congenital Heart Disease (ACHD) Accredited Comprehensive Care Center — the first in Tennessee.

Freedman named director of the Division of Cardiovascular Medicine

Jan. 7, 2021—Jane Freedman, MD, will join Vanderbilt University Medical Center as director of the Division of Cardiovascular Medicine and the physician-in-chief of the Vanderbilt Heart and Vascular Institute, effective Aug. 1.

Muñoz named to key VHVI leadership role

Dec. 17, 2020—Daniel Muñoz, MD, MPA, associate professor of Medicine, has been named the new executive medical director of the Patient Care Center (PCC) at Vanderbilt Heart and Vascular Institute (VHVI), effective Jan. 1, 2021.